United States Imatinib Mesylate Market Report 2016

December 2016 | 98 pages | ID: UBEEBA72B5EEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Imatinib Mesylate

Revenue, means the sales value of Imatinib Mesylate

This report studies sales (consumption) of Imatinib Mesylate in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Sanofi SA (France)
• Wyeth (US)
• GlaxoSmithKline Plc (UK)
• Abbott Laboratories (USA)
• Pfizer Inc. (USA)
• Eli Lilly and Company (US)
• Merck & Co., Inc. (US)
• Warner Chilcott plc (Ireland)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Imatinib Mesylate in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Imatinib Mesylate Market Report 2016

1 IMATINIB MESYLATE OVERVIEW

1.1 Product Overview and Scope of Imatinib Mesylate
1.2 Classification of Imatinib Mesylate
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Imatinib Mesylate
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Imatinib Mesylate (2011-2021)
  1.4.1 United States Imatinib Mesylate Sales and Growth Rate (2011-2021)
  1.4.2 United States Imatinib Mesylate Revenue and Growth Rate (2011-2021)

2 UNITED STATES IMATINIB MESYLATE COMPETITION BY MANUFACTURERS

2.1 United States Imatinib Mesylate Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Imatinib Mesylate Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Imatinib Mesylate Average Price by Manufactures (2015 and 2016)
2.4 Imatinib Mesylate Market Competitive Situation and Trends
  2.4.1 Imatinib Mesylate Market Concentration Rate
  2.4.2 Imatinib Mesylate Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES IMATINIB MESYLATE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Imatinib Mesylate Sales and Market Share by Type (2011-2016)
3.2 United States Imatinib Mesylate Revenue and Market Share by Type (2011-2016)
3.3 United States Imatinib Mesylate Price by Type (2011-2016)
3.4 United States Imatinib Mesylate Sales Growth Rate by Type (2011-2016)

4 UNITED STATES IMATINIB MESYLATE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Imatinib Mesylate Sales and Market Share by Application (2011-2016)
4.2 United States Imatinib Mesylate Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES IMATINIB MESYLATE MANUFACTURERS PROFILES/ANALYSIS

5.1 Sanofi SA (France)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Imatinib Mesylate Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Sanofi SA (France) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Wyeth (US)
  5.2.2 Imatinib Mesylate Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Wyeth (US) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc (UK)
  5.3.2 Imatinib Mesylate Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc (UK) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Abbott Laboratories (USA)
  5.4.2 Imatinib Mesylate Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Abbott Laboratories (USA) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Pfizer Inc. (USA)
  5.5.2 Imatinib Mesylate Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Pfizer Inc. (USA) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Eli Lilly and Company (US)
  5.6.2 Imatinib Mesylate Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Eli Lilly and Company (US) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Merck & Co., Inc. (US)
  5.7.2 Imatinib Mesylate Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Merck & Co., Inc. (US) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Warner Chilcott plc (Ireland)
  5.8.2 Imatinib Mesylate Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Warner Chilcott plc (Ireland) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview

6 IMATINIB MESYLATE MANUFACTURING COST ANALYSIS

6.1 Imatinib Mesylate Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Imatinib Mesylate

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Imatinib Mesylate Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Imatinib Mesylate Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES IMATINIB MESYLATE MARKET FORECAST (2016-2021)

10.1 United States Imatinib Mesylate Sales, Revenue Forecast (2016-2021)
10.2 United States Imatinib Mesylate Sales Forecast by Type (2016-2021)
10.3 United States Imatinib Mesylate Sales Forecast by Application (2016-2021)
10.4 Imatinib Mesylate Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Imatinib Mesylate
Table Classification of Imatinib Mesylate
Figure United States Sales Market Share of Imatinib Mesylate by Type in 2015
Table Application of Imatinib Mesylate
Figure United States Sales Market Share of Imatinib Mesylate by Application in 2015
Figure United States Imatinib Mesylate Sales and Growth Rate (2011-2021)
Figure United States Imatinib Mesylate Revenue and Growth Rate (2011-2021)
Table United States Imatinib Mesylate Sales of Key Manufacturers (2015 and 2016)
Table United States Imatinib Mesylate Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Imatinib Mesylate Sales Share by Manufacturers
Figure 2016 Imatinib Mesylate Sales Share by Manufacturers
Table United States Imatinib Mesylate Revenue by Manufacturers (2015 and 2016)
Table United States Imatinib Mesylate Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Imatinib Mesylate Revenue Share by Manufacturers
Table 2016 United States Imatinib Mesylate Revenue Share by Manufacturers
Table United States Market Imatinib Mesylate Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Imatinib Mesylate Average Price of Key Manufacturers in 2015
Figure Imatinib Mesylate Market Share of Top 3 Manufacturers
Figure Imatinib Mesylate Market Share of Top 5 Manufacturers
Table United States Imatinib Mesylate Sales by Type (2011-2016)
Table United States Imatinib Mesylate Sales Share by Type (2011-2016)
Figure United States Imatinib Mesylate Sales Market Share by Type in 2015
Table United States Imatinib Mesylate Revenue and Market Share by Type (2011-2016)
Table United States Imatinib Mesylate Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Imatinib Mesylate by Type (2011-2016)
Table United States Imatinib Mesylate Price by Type (2011-2016)
Figure United States Imatinib Mesylate Sales Growth Rate by Type (2011-2016)
Table United States Imatinib Mesylate Sales by Application (2011-2016)
Table United States Imatinib Mesylate Sales Market Share by Application (2011-2016)
Figure United States Imatinib Mesylate Sales Market Share by Application in 2015
Table United States Imatinib Mesylate Sales Growth Rate by Application (2011-2016)
Figure United States Imatinib Mesylate Sales Growth Rate by Application (2011-2016)
Table Sanofi SA (France) Basic Information List
Table Sanofi SA (France) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi SA (France) Imatinib Mesylate Sales Market Share (2011-2016)
Table Wyeth (US) Basic Information List
Table Wyeth (US) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wyeth (US) Imatinib Mesylate Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Imatinib Mesylate Sales Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories (USA) Imatinib Mesylate Sales Market Share (2011-2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Inc. (USA) Imatinib Mesylate Sales Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company (US) Imatinib Mesylate Sales Market Share (2011-2016)
Table Merck & Co., Inc. (US) Basic Information List
Table Merck & Co., Inc. (US) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co., Inc. (US) Imatinib Mesylate Sales Market Share (2011-2016)
Table Warner Chilcott plc (Ireland) Basic Information List
Table Warner Chilcott plc (Ireland) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Warner Chilcott plc (Ireland) Imatinib Mesylate Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Imatinib Mesylate
Figure Manufacturing Process Analysis of Imatinib Mesylate
Figure Imatinib Mesylate Industrial Chain Analysis
Table Raw Materials Sources of Imatinib Mesylate Major Manufacturers in 2015
Table Major Buyers of Imatinib Mesylate
Table Distributors/Traders List
Figure United States Imatinib Mesylate Production and Growth Rate Forecast (2016-2021)
Figure United States Imatinib Mesylate Revenue and Growth Rate Forecast (2016-2021)
Table United States Imatinib Mesylate Production Forecast by Type (2016-2021)
Table United States Imatinib Mesylate Consumption Forecast by Application (2016-2021)